Tech Company Financing Transactions
Trivascular Technologies Funding Round
Trivascular Technologies, based in Santa Rosa, scored $65 million from MPM Capital, New Enterprise Associates and Delphi Ventures.
Transaction Overview
Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series A
Investors
MPM Capital (Lead Investor) (James Scopa)
New Enterprise Associates (Lead Investor)
Proceeds Purpose
The funds were used to acquire Trivascular from Boston Scientific and re-start operations.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
3910 Brickway Blvd.
Santa Rosa, CA 95403
USA
Santa Rosa, CA 95403
USA
Phone
Website
Email Address
Overview
Trivascular Technologies is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Chavez
Chief Financial Officer
Michael Kramer
Chief Technical Officer
Michael Chobotov
VP - General Counsel
Kimberley Elting
VP - Manufacturing
Joseph Humphrey
VP - Operations
Vivek Jayaraman
VP - R & D
Robert Whirley
VP - Regulatory Affairs
Shari Quinn
VP - Sales
Rob Woolley
Browse more venture capital transactions:
Prev: 3/31/2008: Naviscan PET Systems venture capital transaction
Next: 3/31/2008: Axentis venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs